Tolvaptan 托伐普坦
CAS 150683-30-0 MFCD09837707
化学结构图
SMILES: CC1=CC(=CC=C1C(=O)N1CCC[C@@H](O)C2C=C(Cl)C=CC1=2)NC(=O)C1=CC=CC=C1C
化学属性
| Mol. Formula | C26H25ClN2O3 |
|---|---|
| Mol. Weight | 448.948 |
别名和识别编码
| Chemical Name | Tolvaptan |
|---|---|
| LabNetwork Molecule ID | LN01374893 |
| Chemical Name Translation | 托伐普坦 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Inomata T.
- [3]. Vaduganathan M, Gheorghiade M, Pang PS, Konstam MA, Zannad F, Swedberg K, Grinfeld L, Burnett JC Jr, Krasa HB, Zimmer C, Blair J, Ouyang J, Maggioni AP; EVEREST investigators.
- [4]. Y Yamamura et al. OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats. J. Pharmacol.
- [5]. RW Schrier et al. Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia. N Engl J Med 2006, 355, 2099-2112.
- Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
- Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
- Exp. Ther. 1998, 287(3), 860-867.
- Exp. Ther. 1998, 287(3), 860-867.
- Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V(2)-receptor an
